Progeria secondary prevention: Difference between revisions

Jump to navigation Jump to search
Line 11: Line 11:
'''Cardiac assessment'''  
'''Cardiac assessment'''  


*In patients with Hutchinson-Gilford progeria syndrome (HGPS) accelerated progressive atherosclerosis is primary concern, so yearly cardiac evaluation should be considered with the following:<ref name="pmid11842974">{{cite journal| author=Ackerman J, Gilbert-Barness E| title=Hutchinson-Gilford progeria syndrome: a pathologic study. | journal=Pediatr Pathol Mol Med | year= 2002 | volume= 21 | issue= 1 | pages= 1-13 | pmid=11842974 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11842974  }}</ref><ref name="pmid21251803">{{cite journal| author=Doubaj Y, Lamzouri A, Elalaoui SC, Laarabi FZ, Sefiani A| title=[Three cases of Hutchinson-Gilford progeria syndrome]. | journal=Arch Pediatr | year= 2011 | volume= 18 | issue= 2 | pages= 156-9 | pmid=21251803 | doi=10.1016/j.arcped.2010.11.014 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21251803  }}</ref>
*In patients with Hutchinson-Gilford progeria syndrome (HGPS) accelerated progressive atherosclerosis is primary concern, so yearly cardiac evaluation should be considered with the following:<ref name="pmid11842974">{{cite journal| author=Ackerman J, Gilbert-Barness E| title=Hutchinson-Gilford progeria syndrome: a pathologic study. | journal=Pediatr Pathol Mol Med | year= 2002 | volume= 21 | issue= 1 | pages= 1-13 | pmid=11842974 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11842974  }}</ref><ref name="pmid21251803">{{cite journal| author=Doubaj Y, Lamzouri A, Elalaoui SC, Laarabi FZ, Sefiani A| title=[Three cases of Hutchinson-Gilford progeria syndrome]. | journal=Arch Pediatr | year= 2011 | volume= 18 | issue= 2 | pages= 156-9 | pmid=21251803 | doi=10.1016/j.arcped.2010.11.014 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21251803 }}</ref><ref name="pmid22991222">{{cite journal| author=Doubaj Y, De Sandre-Giovannoli A, Vera EV, Navarro CL, Elalaoui SC, Tajir M et al.| title=An inherited LMNA gene mutation in atypical Progeria syndrome. | journal=Am J Med Genet A | year= 2012 | volume= 158A | issue= 11 | pages= 2881-7 | pmid=22991222 | doi=10.1002/ajmg.a.35557 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22991222 }}</ref>
**Electrocardiogram (ECG)
**Electrocardiogram (ECG)
**Blood pressure measurement
**Blood pressure measurement

Revision as of 21:01, 6 August 2019

Xyz Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Xyz from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Progeria secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Progeria secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Progeria secondary prevention

CDC on Progeria secondary prevention

Progeria secondary prevention in the news

Blogs on Progeria secondary prevention

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Progeria secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Effective measures for the secondary prevention of Hutchinson-Gilford progeria syndrome (HGPS) include nutritional assessment, assessment of cardiac and neurologic status of the patient, musculoskeletal issues assessment, dental evaluation, ophthalmology evaluation and audiology evaluation.

Secondary Prevention

Effective measures for the secondary prevention of Hutchinson-Gilford progeria syndrome (HGPS) include:[1]

Cardiac assessment

  • In patients with Hutchinson-Gilford progeria syndrome (HGPS) accelerated progressive atherosclerosis is primary concern, so yearly cardiac evaluation should be considered with the following:[2][3][4]
    • Electrocardiogram (ECG)
    • Blood pressure measurement
    • Lipid profile testing
    • Echocardiography

Growth management

  • A complete nutritional assessment which includes weight/height on growth charts of the patient
  • Encourage the patient for frequent small meals to maximize calorie intake
  • Advise on adequate oral hydration should be considered

Neurologic assessment

  • In patients with Hutchinson-Gilford progeria syndrome (HGPS) investigate for any symptoms of the following:[5]
    • Transient ischemic attack (TIA)
    • Stroke
    • Brain and neck magnetic resonance imaging (MRI)
    • Carotid duplex scans- vascular status status

Musculoskeletal assessment

  • Annual Skeletal radiographs are recommended.[6]

Dental assessment

  • In patients with Hutchinson-Gilford progeria syndrome (HGPS) for every six months routine dental evaluation is recommended.

Ophthalmologic assessment

  • In patients with Hutchinson-Gilford progeria syndrome (HGPS) annual ophthalmology assessment is considered for the following:
    • Exposure keratopathy

Hearing assessment

  • In patients with Hutchinson-Gilford progeria syndrome (HGPS) annual hearing assessment should be considered for the following:
    • Conductive hearing loss



References

  1. Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K; et al. (1993). "GeneReviews®". PMID 20301300.
  2. Ackerman J, Gilbert-Barness E (2002). "Hutchinson-Gilford progeria syndrome: a pathologic study". Pediatr Pathol Mol Med. 21 (1): 1–13. PMID 11842974.
  3. Doubaj Y, Lamzouri A, Elalaoui SC, Laarabi FZ, Sefiani A (2011). "[Three cases of Hutchinson-Gilford progeria syndrome]". Arch Pediatr. 18 (2): 156–9. doi:10.1016/j.arcped.2010.11.014. PMID 21251803.
  4. Doubaj Y, De Sandre-Giovannoli A, Vera EV, Navarro CL, Elalaoui SC, Tajir M; et al. (2012). "An inherited LMNA gene mutation in atypical Progeria syndrome". Am J Med Genet A. 158A (11): 2881–7. doi:10.1002/ajmg.a.35557. PMID 22991222.
  5. Doubaj Y, Lamzouri A, Elalaoui SC, Laarabi FZ, Sefiani A (2011). "[Three cases of Hutchinson-Gilford progeria syndrome]". Arch Pediatr. 18 (2): 156–9. doi:10.1016/j.arcped.2010.11.014. PMID 21251803.
  6. Cleveland RH, Gordon LB, Kleinman ME, Miller DT, Gordon CM, Snyder BD; et al. (2012). "A prospective study of radiographic manifestations in Hutchinson-Gilford progeria syndrome". Pediatr Radiol. 42 (9): 1089–98. doi:10.1007/s00247-012-2423-1. PMC 4220680. PMID 22752073.

Template:WH Template:WS